References
- Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A (2011). Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Asian Pac J Cancer Prev, 12, 625-9.
- Breast. In: Edge SB, Byrd DR, Compton CC, et al (2010), eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 347-76.
- Elston CW, Ellis IO (1991). Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from large study with long-term followup. Histopathology, 19, 403-10. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x
- Li CY, Zhang S, Zhang XB, et al (2014). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: A retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. https://doi.org/10.7314/APJCP.2013.14.6.3779
- Ma KK, Chau WW, Wong CHN, et al (2013). Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14. https://doi.org/10.7314/APJCP.2012.13.5.2109
- Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009). Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer, 46, 73-4. https://doi.org/10.4103/0019-509X.48603
- Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD (2000). Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: Correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol, 53, 688-96. https://doi.org/10.1136/jcp.53.9.688
- Rao C, Shetty J, Kishan Prasad HL (2013). Morphological profile and receptor status in breast carcinoma: an institutional study. J Cancer Res Ther. 9, 44-9. https://doi.org/10.4103/0973-1482.110358
- Stead LA, Lash TL, Sobieraj JE, et al (2009). Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res, 11, 18.
- Shet T, Agrawal A, Nadkarni M, et al (2009). Hormone receptors over the last 8 years in a cancer referral center in India: What was and what is? Indian J Pathol Microbiol, 52, 171-4. https://doi.org/10.4103/0377-4929.48909
- Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer at a tertiary care hospital in north India. Indian J Cancer, 47, 16‑22. https://doi.org/10.4103/0019-509X.58853
- Sin ghai R, Patil VW, Patil AV (2011). Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian women. Int J App Basic Med Res, 1, 15-9. https://doi.org/10.4103/2229-516X.81974
- Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev. 13, 5047-52. https://doi.org/10.7314/APJCP.2012.13.10.5047
- Sedighi A, Hamed EA, Mohammadian K, Behnood S, Kalaghchi B (2013). Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran. Asian Pac J Cancer Prev, 14, 7381-3. https://doi.org/10.7314/APJCP.2013.14.12.7381
- Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- Taucher S, Rudas M, Mader RM, et al (2003). Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer, 98, 2547-53. https://doi.org/10.1002/cncr.11828
-
Zhou XL, Fan W, Yang G, Yu MX (2014). The clinical significance of PR, ER, NF-
$\kappa$ B, and TNF-$\alpha$ in breast cancer. Dis Markers, 2014, 494581. - Zubeda S, Kaipa PR, Shaik NA, et al (2014). HER2/neu status: A neglected marker of prognostication and management of breast cancer patients in India. Asian Pac J Cancer Prev. 14, 2231-5. https://doi.org/10.7314/APJCP.2013.14.4.2231